Company Filing History:
Years Active: 2011-2014
Title: The Innovative Contributions of Steven Gurley
Introduction: Steven Gurley is a prominent inventor based in Memphis, TN, who has made significant strides in the field of cannabinoid research. With a total of 11 patents to his name, Gurley has become a notable figure in the development of new therapeutic compounds related to cannabinoids, showcasing his innovation and commitment to advancing medical treatments.
Latest Patents: Among Steven Gurley's most recent patents are those related to pyridine and pyrimidine non-classical cannabinoid compounds. His patent titled "Pyridine Non-Classical Cannabinoid Compounds and Related Methods of Use" describes compounds that can be utilized in the treatment of disorders mediated by cannabinoid receptors. The formula encompassing these compounds is defined in detail, highlighting their potential for therapeutic applications. Similarly, his "Pyrimidine Non-Classical Cannabinoid Compounds and Related Methods of Use" patent outlines analogous compounds with possible medical benefits, further emphasizing his innovative approach to cannabinoid research.
Career Highlights: Steven Gurley works at the University of Tennessee Research Foundation, where he has dedicated his research efforts to cannabinoid compounds and their applications. His work not only demonstrates his expertise in chemistry and medicinal applications but also underscores his role in contributing to advancements in healthcare.
Collaborations: Throughout his career, Steven has collaborated with notable colleagues in his field, including Bob M Moore, II and Suni Mustafa. These partnerships have allowed for a breadth of knowledge sharing and innovation, further enhancing the impact of their research.
Conclusion: Steven Gurley stands out as an inventor who is pushing the boundaries of cannabinoid research. His eleven patents reflect a commitment to innovation and a desire to improve treatment options for various health disorders. As he continues his work at the University of Tennessee Research Foundation, the potential for future contributions to the field remains promising.